Back to "Також виявлено вірогідне зниження рівня ..."
Claim
Strong Support
causal
Analysis v3

In people with type 2 diabetes and chronic kidney disease, taking vitamin D supplements for three months lowers parathyroid hormone levels from 74.9 pg/mL to 64.5 pg/mL, which reflects improved...

61
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

Vitamin D pills increase the active form of vitamin D in the body, which helps the intestines and kidneys hold onto more calcium. When calcium levels rise, the parathyroid glands stop overproducing parathyroid hormone. In kidney disease, a protein traps too much vitamin D, making it harder, but...

Most probable mechanism

In Simple Terms

When vitamin D supplements are taken, more active vitamin D is made in the kidneys, which helps the intestines absorb more calcium from food. This raises blood calcium levels, which signals the parathyroid glands to stop making too much parathyroid hormone. In people with kidney disease, too much binding protein traps vitamin D, making it harder for this process to work, but enough supplementation can still overcome this and lower the hormone.

Causal chain
1

Oral vitamin D supplementation increases circulating 25-hydroxyvitamin D levels.

Supported by evidence
which leads to
2

Elevated 25-hydroxyvitamin D enhances renal conversion to 1,25-dihydroxyvitamin D, the biologically active form.

Supported by evidence
which leads to
3

Vitamin D-binding protein sequesters a large fraction of circulating vitamin D and its metabolites, reducing the pool of free, bioavailable active vitamin D.

Verified by multiple studies
which leads to
4

Reduced bioavailability of 1,25-dihydroxyvitamin D impairs intestinal calcium absorption and renal calcium reabsorption, maintaining hypocalcemia.

Verified by multiple studies
which leads to
5

Sustained hypocalcemia stimulates parathyroid gland secretion of parathyroid hormone.

Verified by multiple studies
which leads to
6

Adequate vitamin D supplementation overcomes binding protein sequestration, increasing free 1,25-dihydroxyvitamin D to restore intestinal calcium absorption and renal calcium reabsorption.

Supported by evidence
which leads to
7

Restored serum calcium levels directly inhibit parathyroid hormone synthesis and secretion via calcium-sensing receptors on parathyroid cells.

Verified by multiple studies

Evidence from Studies

Supporting (1)

61

Community contributions welcome

61

Features of correction of vitamin D deficiency in patients with diabetic kidney disease: the role of vitamin D-binding protein

Cohort Study
Human

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Features of correction of vitamin D deficiency in patients with diabetic kidney disease: the role of vitamin D-binding protein

Score: 61
DOI: 10.22141/2307-1257.14.2.2025.514

Similar Assertions

People with type 2 diabetes and early kidney disease consistently show low vitamin D levels in their blood, and the worse their kidney function, the lower their vitamin D levels tend to be.

61
0
77%

In people with type 2 diabetes and early kidney disease, those with higher levels of vitamin D-binding protein in their blood at the start of treatment are less likely to reach healthy vitamin D levels after three months of taking vitamin D supplements.

61
0
74%

In people with type 2 diabetes and kidney disease, taking 4000 IU of vitamin D daily for three months raises blood levels of vitamin D from 12.1 ng/mL to 34.5 ng/mL.

61
0
74%

In people with type 2 diabetes, higher levels of vitamin D-binding protein in the blood are consistently observed as kidney function worsens, with measurable increases from 93.6 ng/mL to 132.8 ng/mL as eGFR declines from ≥90 to 30–60 mL/min/1.73m².

61
0
71%